Ron Philip, Spark Therapeutics CEO

Roche and blue­bird bio set­tle year-long trade­mark case, but keep qui­et on the de­tails

It ap­pears the sparks fly­ing be­tween Roche and blue­bird­bio in a Delaware fed­er­al court have fiz­zled.

Blue­bird and Roche’s Spark Ther­a­peu­tics to­geth­er filed a mo­tion …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.